What Is STD Testing 12 Types

When you come to an OB-GYN with vaginitis, the test we recommend first is the sexually transmitted infection test, commonly called STD-12. In the exam room, it has become familiar enough that many people first say, "I came to get an STD test," but when actually asked "what exactly this test checks" and "when to get it for an accurate result," they find it hard to answer. STD stands for Sexually Transmitted Disease—that is, a test to check whether there is an infection that can be transmitted through sexual contact. In this article, rather than interpreting test results, I will organize it centering on which organisms the panel contains and at what time point it should be taken.

The STD-12 test does not guess by looking at symptoms; it directly finds the genes of the causative organism in the discharge. When you come in, we first insert a speculum to observe the appearance of the discharge, and collect the discharge with a small brush. When this specimen is placed in a specimen tube and sent to the lab, the result usually comes out within 1 to 7 days.

The core principle of this test is PCR, the polymerase chain reaction. Because the DNA of organisms in discharge is present in very small amounts and hard to confirm as is, it is a method of amplifying and detecting the targeted gene fragment. The test types are broadly divided into two.

• STD Multiplex PCR: a method of looking at several organisms bundled together at once, with various bundles such as 7, 8, 9, 12, and 16 types.
• STD Real Time Multiplex PCR: a method of measuring the amplification process in real time, with 7, 8, 9, 16, 17 types, and so on.

Women usually have 12 types performed, while for men 16 or 17 types are mainly done. The U.S. Centers for Disease Control and Prevention (CDC) 2021 STI treatment guidelines also recommend nucleic acid amplification testing (the NAAT class) using discharge/urine specimens as the standard method, since core infections such as gonorrhea and chlamydia are hard to judge by symptoms alone.

Because the cause of vaginitis is not a single thing, several organisms are bundled and looked at at once. In the exam room, it is common for the causative organism to be entirely different even when the discharge appearance looks similar. The background of foul-smelling discharge may be bacterial vaginosis, or it may be trichomonas, and chlamydia is sometimes confirmed even when there are almost no symptoms. So rather than a single test that "pinpoints just one," the method of looking at common causative organisms together as one bundle (panel) has taken root in clinical practice.

The 12-type panel typically includes the following organisms. Since the composition differs slightly by bundle, organizing it around the important organisms gives the following.

There is an important point here. A broad panel does not mean every detected organism must be treated. The CDC 2021 guidelines do not recommend routine screening for Mycoplasma genitalium in asymptomatic women. It means that interpreting along with symptoms and context is more important than detection itself. Viral infections such as HPV are a separate testing area from this organism test panel, and the details are covered separately in HPV and cervical cancer intensive care.

There are people for whom testing is recommended even without symptoms. Chlamydia and gonorrhea are not infrequently passed without almost any symptoms in women, so if you only wait for symptoms, diagnosis can be delayed.

In the exam room, many people ask back, "Why test when there are no symptoms?" But asymptomatic infection can lead to complications such as pelvic inflammatory disease without the person knowing, or be transmitted to a partner, so screening-purpose testing has meaning. If you suffer from recurring discharge abnormalities or recurrent vaginitis, confirming the causative organism is the first step, and you can also refer to the recurring vaginitis/uteritis item.

If you are hesitant about whether testing is needed in your situation, or which bundle is appropriate, it is also fine to simply inquire first.

Even for the same test, the reliability of the result differs depending on when you take it. This is because sexually transmitted organisms are not detected immediately right after exposure; a certain amount of time is needed until the organism multiplies sufficiently to a detectable amount. This is why it is hard to feel reassured by a negative result from testing the day after exposure.

Generalizing from published clinical data, for major organisms there is a gap between the time of exposure and the time of detectability.

In summary, when getting tested out of concern about a specific exposure, it is known that a time point about 1–2 weeks later is more accurate than right after exposure. Even if you tested right after exposure and got a negative, if you have symptoms or great concern, it is safer to check again after about 2 weeks. However, in cases where symptoms such as discharge/itching are already clear, treatment is sometimes started first, depending on the condition, while waiting for the test result.

I also want to point out that a single negative is not the end. Even after receiving treatment, a process of checking again after a certain period is needed. The CDC 2021 guidelines recommend retesting about 3 months after treatment when treated for chlamydia/gonorrhea. This is to catch reinfection rather than treatment failure.

From clinical experience, reinfection often arises not because your own treatment was wrong but because the partner did not get treated together. So when discussing testing and treatment, we also recommend partner co-testing/treatment. If only one side is treated, it can be passed back like ping-pong.

Organizing the test timing:

• When you have symptoms: test immediately; if needed, start treatment before the result
• When concerned about a specific exposure: about 1–2 weeks after exposure
• Confirmation after treatment: retest about 3 months later to check for reinfection
• When risk factors persist: regular screening

If you are confused about the test interval or when to come in, the guidance how often should I visit for gynecological treatment is also helpful.

Let me organize a few frequently asked questions before testing. First, the test itself is a process of collecting discharge with a brush, and in most cases it ends short, without great discomfort. The result comes out within 1 to 7 days depending on the test type and the lab's circumstances.

Not using vaginal cleansers or vaginal suppositories for a few days before the test is advantageous for specimen collection, and it is best to avoid the menstrual period if possible. Since the type of test bundle (7, 9, 12, 16 types, etc.) varies by symptoms and situation, looking at the most types unconditionally is not the right answer. It is more reasonable to determine the appropriate panel together after confirming the discharge appearance in the exam room. Costs vary depending on the test bundle and whether insurance applies, so they are provided after a consultation.

I want to emphasize that an STD test is not a test you get "because of promiscuous sexual life," but one of the basic tests for checking women's health. If you have changes in discharge or vague worry, it is more comforting to get checked once than to search alone and feel anxious. On the same topic, what is STD testing — the 12-organism STD test story also covers testing overall.

The STD-12 test is a panel test that confirms common sexually transmitted organisms at once, and if you understand what it looks at (panel composition) and when to get it (testing timing), you can accept the result far more calmly. Not every detected organism is immediately a target for treatment, and interpretation considering the time of exposure and the retest timing is key. If you have symptoms or are concerned about a specific exposure, getting an accurate test at the appropriate time is the fastest way to reduce vague anxiety.

Author: Lee Donghee Chief Director · Obstetrician-Gynecologist · View provider profile

First published January 29, 2024 · Last reviewed May 30, 2026

References: CDC Sexually Transmitted Infections Treatment Guidelines (2021), CDC STI Screening Recommendations (2021), U.S. Preventive Services Task Force Chlamydia and Gonorrhea Screening (2021)

This article is intended to provide general health information and does not replace individual diagnosis or treatment. If you have symptoms, please consult through a medical visit.